The results of three-chamber testing revealed significant social behavioral deficits in the MIA mice compared to controls
This single case does not establish causation, but it raises a flag that clinicians should be aware of, particularly in patients with pre-existing SLE or lupus-like features
Clinical trials have shown Semaglutide GLP-1 to help patients lose an average of 15% of their body weight, and liraglutide has demonstrated significant reductions in body weight, body mass index (BMI), and waist circumference
11 Initial research with oral glutathione, not in the liposomal form, did not show elevated glutathione levels or decreases in oxidative stress markers
While they are not FDA-approved in the same way branded drugs are, they provide a vital alternative for patients who need personalized dosing or who cannot access branded products due to national shortages
E.Abdul-SalamV